AI and the Future of Medical Affairs: From Information Provider to Strategic Intelligence Hub

Author(s): Richard Meyer

Artificial intelligence is poised to fundamentally reshape Medical Affairs within pharmaceutical and biotechnology companies. While much of the discussion around AI has focused on drug discovery and clinical development, Medical Affairs may ultimately become one of the greatest beneficiaries of the technology, but only if it’s used as a tool, not a replacement for people.

Medical Affairs sits at the intersection of science, clinical practice, commercial strategy, and patient care. Its mission has always been to generate and communicate evidence while serving as the scientific bridge between industry and healthcare professionals. AI will not replace this mission—it will amplify it.